+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ADMA Biologics Inc - logo

ADMA Biologics is a late stage biopharmaceutical company that develops specialty plasma-based biologics for the treatment and prevention of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical study for the treatment of primary immune deficiency disease. ADMA Biologics was founded in 2004 and is based in Ramsey, New Jersey.

Asia Pacific Plasma Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By End User, By Product Type (Immunoglobulin, Albumin, Plasma derived factor VIII, and Others), By Application, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

Asia Pacific Plasma Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By End User, By Product Type (Immunoglobulin, Albumin, Plasma derived factor VIII, and Others), By Application, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 104 Pages
  • Asia Pacific
From
North America Plasma Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By End User, By Product Type (Immunoglobulin, Albumin, Plasma derived factor VIII, and Others), By Application, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

North America Plasma Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By End User, By Product Type (Immunoglobulin, Albumin, Plasma derived factor VIII, and Others), By Application, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 94 Pages
  • North America
From
LAMEA Plasma Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By End User, By Product Type (Immunoglobulin, Albumin, Plasma derived factor VIII, and Others), By Application, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

LAMEA Plasma Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By End User, By Product Type (Immunoglobulin, Albumin, Plasma derived factor VIII, and Others), By Application, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 104 Pages
  • Middle East, Africa
From
Europe Plasma Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By End User, By Product Type (Immunoglobulin, Albumin, Plasma derived factor VIII, and Others), By Application, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

Europe Plasma Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By End User, By Product Type (Immunoglobulin, Albumin, Plasma derived factor VIII, and Others), By Application, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 104 Pages
  • Europe
From
Critical Care Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025 - Product Thumbnail Image

Critical Care Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • Report
  • September 2019
  • 100 Pages
  • Global
From
ADMA Biologics Inc (ADMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

ADMA Biologics Inc (ADMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 88 Pages
From
Comprehensive Report on ADMA Biologics Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on ADMA Biologics Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
ADMA Biologics Inc (ADMA) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

ADMA Biologics Inc (ADMA) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • July 2023
  • 59 Pages
From
Loading Indicator